| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |